XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 24.42%8.44M | -51.03%25.08M | -81.71%6.79M | 170.18%51.21M | 230.91%37.1M | -84.21%18.95M | -70.72%11.21M | -24.92%120M | -57.60%38.29M | -87.50%159.84M |
Operating income | 24.42%8.44M | -51.03%25.08M | -81.71%6.79M | 170.18%51.21M | 230.91%37.1M | -84.21%18.95M | -70.72%11.21M | -24.92%120M | -57.60%38.29M | -87.50%159.84M |
Cost of sales | 23.86%-3M | 83.76%-6.61M | 88.51%-3.94M | -275.30%-40.73M | -400.96%-34.32M | 85.30%-10.85M | 36.99%-6.85M | 13.10%-73.84M | 79.98%-10.87M | 89.96%-84.97M |
Operating expenses | 23.86%-3M | 83.76%-6.61M | 88.51%-3.94M | -275.30%-40.73M | -400.96%-34.32M | 85.30%-10.85M | 36.99%-6.85M | 13.10%-73.84M | 79.98%-10.87M | 89.96%-84.97M |
Gross profit | 91.41%5.44M | 76.17%18.46M | 2.34%2.84M | 29.37%10.48M | -36.31%2.78M | -82.45%8.1M | -84.10%4.36M | -38.35%46.16M | -23.83%27.42M | -82.66%74.86M |
Selling expenses | ---- | 79.73%-1.37M | ---- | ---6.74M | ---- | ---- | ---- | ---- | ---- | ---- |
Administrative expenses | ---- | 28.12%-27.48M | ---- | ---38.23M | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus | ---- | -1,983.62%-715.58M | ---- | ---34.34M | ---- | ---- | ---- | ---- | ---- | ---- |
-Changes in the fair value of investment property | ---- | -1,983.62%-715.58M | ---- | ---34.34M | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | ---- | 85.49%-6.94M | ---- | ---47.8M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of property, machinery and equipment | ---- | 94.65%-2.5M | ---- | ---46.79M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | -336.42%-4.43M | ---- | ---1.02M | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | -2,660.70%-128.84M | 116.71%21.23M | 96.36%-4.67M | 35.31%-127.04M | -234.00%-128.06M | -806.34%-196.4M | -752.04%-38.34M | 8.46%-21.67M | 12.19%5.88M | -137.87%-23.67M |
Operating profit | -6,661.75%-123.4M | -192.05%-711.67M | 98.54%-1.83M | -29.41%-243.69M | -268.68%-125.28M | -869.05%-188.3M | -202.05%-33.98M | -52.17%24.49M | -19.26%33.3M | -89.65%51.19M |
Financing cost | 3.88%-287.66M | 2.21%-559.93M | -14.68%-299.26M | -389.56%-572.58M | -303.58%-260.95M | 9.03%-116.96M | -13.11%-64.66M | 22.95%-128.58M | 37.00%-57.16M | -6.63%-166.87M |
Share of profit from joint venture company | -82.79%51.43M | 803.91%181.98M | 1,343.09%298.91M | 89.16%-25.85M | -142.03%-24.05M | -3,015.55%-238.43M | -822.02%-9.94M | -183.23%-7.65M | --1.38M | ---2.7M |
Special items of earning before tax | 38.79%-18.62M | ---- | 26.77%-30.42M | ---- | 62.05%-41.54M | -3,079.52%-1.62B | -279.40%-109.46M | -111.35%-50.8M | -82.81%61.01M | 488.91%447.72M |
Earning before tax | -1,060.72%-378.26M | -29.39%-1.09B | 92.79%-32.59M | 60.99%-842.12M | -107.22%-451.8M | -1,228.22%-2.16B | -665.95%-218.03M | -149.36%-162.55M | -87.39%38.53M | 47.86%329.33M |
Tax | ---- | 884.39%178.9M | 28.06%4.38M | -106.39%-22.81M | -58.89%3.42M | 1,023.76%356.81M | 125.37%8.31M | 77.40%-38.63M | 71.21%-32.77M | -78.37%-170.88M |
After-tax profit from continuing operations | -1,240.81%-378.26M | -5.29%-910.72M | 93.71%-28.21M | 52.01%-864.93M | -113.80%-448.39M | -795.82%-1.8B | -3,745.39%-209.72M | -226.96%-201.17M | -97.00%5.75M | 24.83%158.45M |
Earning after tax | -1,240.81%-378.26M | -5.29%-910.72M | 93.71%-28.21M | 52.01%-864.93M | -113.80%-448.39M | -795.82%-1.8B | -3,745.39%-209.72M | -226.96%-201.17M | -97.00%5.75M | 24.83%158.45M |
Minority profit | 83.15%-1.6M | -64.95%-7.06M | -164.59%-9.48M | 88.43%-4.28M | -443.85%-3.58M | -2,623.18%-37.01M | 64.97%-659K | 8.36%-1.36M | -46.50%-1.88M | -113.06%-1.48M |
Profit attributable to shareholders | -1,911.20%-376.66M | -5.00%-903.66M | 95.79%-18.73M | 51.24%-860.65M | -112.76%-444.8M | -783.40%-1.77B | -2,838.54%-209.06M | -224.94%-199.81M | -96.04%7.63M | 38.38%159.93M |
Basic earnings per share | -1,785.71%-1.32 | -5.32%-3.17 | 95.51%-0.07 | 51.32%-3.01 | -112.75%-1.558 | -783.38%-6.1828 | -2,812.22%-0.7323 | -215.55%-0.6999 | -96.32%0.027 | 37.85%0.6057 |
Diluted earnings per share | -1,785.71%-1.32 | -5.32%-3.17 | 95.51%-0.07 | 51.32%-3.01 | -112.75%-1.558 | -783.38%-6.1828 | -2,812.22%-0.7323 | -234.47%-0.6999 | -94.26%0.027 | 26.03%0.5205 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | -- | -- | -- | -- | -- | -- | CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.